Characterization of virulence factors of Aeromonas isolated from children with and without diarrhoea in Tripoli, Libya.

During September 1992-August 1993, stool samples from 157 children with diarrhoea and 157 matched healthy controls were examined for the presence of Aeromonas and other enteropathogens. Aeromonas strains were tested for haemolytic activity, haemagglutination patterns, and antibiotic susceptibility. In total, 62 Aeromonas were isolated, of which 27 (17.2%) were from children with diarrhoea and 35 (22.3%) from healthy controls. Only 23 (14.6%) of the diarrhoeal children and 28 (17.8%) of the healthy controls were positive for Aeromonas; of which, 4 (2.5%) of the diarrhoeal children and 6 (3.8%) of the healthy controls showed multiple species. Aeromonas hydrophila was isolated from 5 (3.2%) children with diarrhoea and from 9 (6.4%) controls, A. veronii bv sobria from 8 (5.1%) and 7 (4.5%), A. caviae from 13 (8.3%) and 17 (10.8%), and A. schubertii from 1 (0.6%) and 2 (1.3%) respectively. No significant difference in the haemolytic activity of Aeromonas was found between diarrhoeal and healthy children. However, a significant difference (p < 0.002) was observed in mannose-resistant haemagglutination (MRHA) by diarrhoeal isolates of Aeromonas (7/27, 26%) compared to the healthy controls (1/35, 3%). Aeromonas strains were uniformly sensitive to ciprofloxacin, gentamicin, and nalidixic acid. The results of this study suggest that A. caviae strains may be associated with diarrhoea in children and MRHA may be used as one of the virulence markers for distinguishing between Aeromonas isolated from diarrhoeal children and healthy controls or environmental isolates.

[1]  A. Eley,et al.  Virulence properties of clinically significant Aeromonas species: evidence for pathogenicity , 1997 .

[2]  I. C. Macrae,et al.  Cytotoxic and haemagglutinating activities of motile Aeromonas species. , 1994, Journal of Medical Microbiology.

[3]  T. Kimura,et al.  Adhesion to and invasion of human colon carcinoma Caco-2 cells by Aeromonas strains. , 1994, Journal of medical microbiology.

[4]  S. Kirov,et al.  Adherence to HEp-2 cells and enteropathogenic potential of Aeromonas spp. , 1993, Epidemiology and Infection.

[5]  D. Singh,et al.  Haemagglutinating activity, serum sensitivity and enterotoxigenicity of Aeromonas spp. , 1993, Journal of medical microbiology.

[6]  E. Azizi,et al.  A 15-year study of the role of Aeromonas spp. in gastroenteritis in hospitalised children. , 1992, Journal of medical microbiology.

[7]  R. Spencer,et al.  Aeromonas spp as a potential cause of diarrhoea in children. , 1992, Journal of clinical pathology.

[8]  D. Singh,et al.  Enterotoxicity of clinical and environmental isolates of Aeromonas spp. , 1992, Journal of medical microbiology.

[9]  D. Singh,et al.  Haemolysin and enterotoxin production by Aeromonas caviae isolated from diarrhoeal patients, fish and environment. , 1992, Journal of diarrhoeal diseases research.

[10]  S. Joseph,et al.  Aerokey II: a flexible key for identifying clinical Aeromonas species , 1991, Journal of clinical microbiology.

[11]  E. Bottone,et al.  Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae , 1990, Journal of clinical microbiology.

[12]  F. Eko,et al.  Characterization and significance of Aeromonas spp. isolated from diarrhoeic stools in Nigeria. , 1989, The Journal of tropical medicine and hygiene.

[13]  H. Geiss,et al.  Aeromonas as a human pathogen. , 1989, Critical reviews in microbiology.

[14]  V. S. San Joaquin,et al.  Aeromonas-associated gastroenteritis in children. , 1988, The Pediatric infectious disease journal.

[15]  N P Moyer,et al.  Clinical significance of Aeromonas species isolated from patients with diarrhea , 1987, Journal of clinical microbiology.

[16]  S. Holmberg,et al.  Aeromonas intestinal infections in the United States. , 1986, Annals of internal medicine.

[17]  S. M. Kirov,et al.  Virulence characteristics of Aeromonas spp. in relation to source and biotype , 1986, Journal of clinical microbiology.

[18]  L. Marri,et al.  Prevalence, species differentiation, and toxigenicity of Aeromonas strains in cases of childhood gastroenteritis and in controls , 1986, Journal of clinical microbiology.

[19]  H. Dupont,et al.  Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans , 1985, Infection and immunity.

[20]  B. Chang,et al.  Invasion of HEp-2 cells by fecal isolates of Aeromonas hydrophila , 1985, Infection and immunity.

[21]  M. Cooper,et al.  Biotyping and virulence factors in clinical and environmental isolates of Aeromonas species , 1984, Applied and environmental microbiology.

[22]  M. Lesmana,et al.  Hemagglutination patterns of Aeromonas spp. in relation to biotype and source , 1984, Journal of clinical microbiology.

[23]  J. Janda,et al.  Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum , 1984, Journal of clinical microbiology.

[24]  Michael Gracey,et al.  AEROMONAS-ASSOCIATED GASTROENTERITIS , 1982, The Lancet.

[25]  P. Echeverria,et al.  Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand , 1982, Infection and immunity.

[26]  V. Burke,et al.  Biochemical characteristics of enterotoxigenic Aeromonas spp , 1982, Journal of clinical microbiology.

[27]  R. J. Berry,et al.  Exotoxins of Aeromonas hydrophila. , 1981, The Australian journal of experimental biology and medical science.

[28]  T. L. Overman Antimicrobial susceptibility of Aeromonas hydrophila , 1980, Antimicrobial Agents and Chemotherapy.

[29]  T. Trust,et al.  Hemagglutination properties and adherence ability of Aeromonas hydrophila , 1980, Infection and immunity.

[30]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.